SEC Form 3 · accession 0000899243-17-012125
Savara Inc · SVRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
a/s Serenova
10% Owner
Period of report
Apr 27, 2017
Accepted (ET)
May 8, 2017 · 11:27 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001160308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,965,400 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 393,080 shares held in escrow by Savara Inc. until July 19, 2017 pursuant to the terms of the Business Transfer Agreement dated May 13, 2016 between Serendex Pharmaceuticals A/S and Savara Inc.